Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.

Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, Kanungi J, Singh S, Haberer J, Priddy F, Sanders EJ.

AIDS Behav. 2013 Jul;17(6):2162-72. doi: 10.1007/s10461-012-0317-8.

PMID:
23080358
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.

Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Priddy FH.

PLoS One. 2012;7(4):e33103. doi: 10.1371/journal.pone.0033103. Epub 2012 Apr 12.

PMID:
22511916
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand.

Tangmunkongvorakul A, Chariyalertsak S, Amico KR, Saokhieo P, Wannalak V, Sangangamsakun T, Goicochea P, Grant R.

AIDS Care. 2013 Aug;25(8):961-7. doi: 10.1080/09540121.2012.748871. Epub 2012 Dec 19.

PMID:
23252473
[PubMed - indexed for MEDLINE]
4.

Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial.

Kibengo FM, Ruzagira E, Katende D, Bwanika AN, Bahemuka U, Haberer JE, Bangsberg DR, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Kamali A, Priddy FH.

PLoS One. 2013 Sep 26;8(9):e74314. doi: 10.1371/journal.pone.0074314. eCollection 2013.

PMID:
24086333
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco.

Gilmore HJ, Liu A, Koester KA, Amico KR, McMahan V, Goicochea P, Vargas L, Lubensky D, Buchbinder S, Grant R.

AIDS Patient Care STDS. 2013 Oct;27(10):560-6. doi: 10.1089/apc.2013.0116.

PMID:
24093809
[PubMed - indexed for MEDLINE]
6.

Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.

Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, Thomas KK, Donnell D, Krows M, Kidoguchi L, Celum C, Bangsberg DR.

PLoS Med. 2013;10(9):e1001511. doi: 10.1371/journal.pmed.1001511. Epub 2013 Sep 10.

PMID:
24058300
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.

Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, Safren S, Tumwesigye E, Celum CL, Bangsberg DR.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):463-8. doi: 10.1097/QAI.0b013e31824a060b.

PMID:
22267018
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France.

Lorente N, Fugon L, Carrieri MP, Andreo C, Le Gall JM, Cook E, Aboulker JP, Capitant C, Molina JM, Spire B.

AIDS Care. 2012;24(4):468-77. doi: 10.1080/09540121.2011.626394. Epub 2011 Nov 15.

PMID:
22085083
[PubMed - indexed for MEDLINE]
9.

From modeling to morals: imagining the future of HIV PREP in Lesotho.

Kenworthy NJ, Bulled N.

Dev World Bioeth. 2013 Aug;13(2):70-8. doi: 10.1111/dewb.12029. Epub 2013 Jun 25.

PMID:
23800326
[PubMed - indexed for MEDLINE]
10.

Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals.

Okwundu CI, Uthman OA, Okoromah CA.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD007189. doi: 10.1002/14651858.CD007189.pub3. Review.

PMID:
22786505
[PubMed - indexed for MEDLINE]
11.

Knowledge of and interest in using preexposure prophylaxis for HIV prevention among men who have sex with men in Thailand.

Sineath RC, Finneran C, Sullivan P, Sanchez T, Smith DK, Griensven Fv, Wimonsate W, Stephenson R.

J Int Assoc Provid AIDS Care. 2013 Jul-Aug;12(4):227-31. doi: 10.1177/2325957413488184. Epub 2013 May 24.

PMID:
23708677
[PubMed - indexed for MEDLINE]
12.

Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women.

Curran K, Mugo NR, Kurth A, Ngure K, Heffron R, Donnell D, Celum C, Baeten JM.

AIDS Behav. 2013 Nov;17(9):2977-85. doi: 10.1007/s10461-013-0510-4.

PMID:
23695519
[PubMed - indexed for MEDLINE]
13.

From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City.

Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL.

AIDS Patient Care STDS. 2013 Apr;27(4):248-54. doi: 10.1089/apc.2012.0419.

PMID:
23565928
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool.

Cohen J.

Science. 2010 Dec 3;330(6009):1298-9. doi: 10.1126/science.330.6009.1298. No abstract available.

PMID:
21127220
[PubMed - indexed for MEDLINE]
15.

Emtricitabine/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis.

Plosker GL.

Drugs. 2013 Mar;73(3):279-91. doi: 10.1007/s40265-013-0024-4. Review.

PMID:
23444256
[PubMed - indexed for MEDLINE]
16.

What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review.

Krakower D, Mayer KH.

Ann Intern Med. 2012 Oct 2;157(7):490-7. Review.

PMID:
22821365
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Early end for FEM-PrEP HIV prevention trial.

[No authors listed]

AIDS Patient Care STDS. 2011 Jun;25(6):383. doi: 10.1089/apc.2011.9874. No abstract available.

PMID:
21612547
[PubMed - indexed for MEDLINE]
18.

Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis.

Zheng Q, Ruone S, Switzer WM, Heneine W, GarcĂ­a-Lerma JG.

Retrovirology. 2012 May 9;9:40. doi: 10.1186/1742-4690-9-40.

PMID:
22571771
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Supporting study product use and accuracy in self-report in the iPrEx study: next step counseling and neutral assessment.

R Amico K, McMahan V, Goicochea P, Vargas L, Marcus JL, Grant RM, Liu A.

AIDS Behav. 2012 Jul;16(5):1243-59. doi: 10.1007/s10461-012-0182-5.

PMID:
22460228
[PubMed - indexed for MEDLINE]
20.

Considerations regarding antiretroviral chemoprophylaxis in MSM.

Poynten IM, Zablotska I, Grulich AE.

Curr Opin HIV AIDS. 2012 Nov;7(6):549-56. doi: 10.1097/COH.0b013e3283582c71. Review.

PMID:
22918448
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk